A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies

Recruiting · NCT07606066 · Observational (researchers observe without assigning treatment) · Lead sponsor: AstraZeneca

View the official record on ClinicalTrials.gov →

Interventions studied

Procedure: assessment

What this trial is about

The purpose of this study is to identify and characterize patients with known Type 2 Diabetes Mellitus (T2DM) for possible participation in ongoing or future T2DM clinical studies, and to characterize trends in key concomitant medication use in this patient population across different geographical regions.

Who can take part

Age range

18 Years and older

Sex

All (male and female)

Healthy volunteers

No - a diagnosis or condition is required

Phase

Not specified

Study type

Observational (researchers observe without assigning treatment)

Inclusion criteria

Participants must be ≥ 18 years of age at the time of signing the ICF.
Patients with a diagnosis of T2DM, test- or documentation-confirmed as per World
Health Organization or local diagnostic standards, inadequately managed with:
Lifestyle management alone, AND/OR
A stable dose of background glucose-lowering medication(s) for T2DM (As specified in the Protocol) for at least 45 days prior to signing the ICF.
Expresses interest in participating in an ongoing or future T2DM clinical study, is motivated and willing to make themselves available for the duration of the study, and is able to follow study procedures as required.
Provision of signed and dated written informed consent (As specified in the Protocol) before any study-specific procedures, sampling, or analysis.

Exclusion criteria

Current or planned use of GLP-1 RAs prohibited in ongoing or future T2DM studies evaluating the efficacy and safety of investigational GLP-1 RAs (As specified in the Protocol).
Diagnosed with Type 1 diabetes mellitus.
Known pregnancy at the time of visit or having the intention to become pregnant.

Where it is running

60 locations listed across 11 US states.

Research Site - Peoria, Arizona, United States
Research Site - Little Rock, Arkansas, United States
Research Site - Lincoln, California, United States
Research Site - Jacksonville, Florida, United States
Research Site - Lake City, Florida, United States
Research Site - Leesburg, Florida, United States
Research Site - Ocoee, Florida, United States
Research Site - Decatur, Georgia, United States
Research Site - Melrose Park, Illinois, United States
Research Site - El Dorado, Kansas, United States
Research Site - Potomac, Maryland, United States
Research Site - Maumee, Ohio, United States
Research Site - Gaffney, South Carolina, United States
Research Site - Renton, Washington, United States
Research Site - Adana, Turkey (Türkiye)
Research Site - Adana, Turkey (Türkiye)
Research Site - Ankara, Turkey (Türkiye)
Research Site - Barretos, Brazil
Research Site - Brasília, Brazil
Research Site - Budapest, Hungary
Research Site - Budapest, Hungary
Research Site - Budapest, Hungary
Research Site - Gaziantep, Turkey (Türkiye)
Research Site - Istanbul, Turkey (Türkiye)
Research Site - Istanbul, Turkey (Türkiye)
Research Site - Kayseri, Turkey (Türkiye)
Research Site - Poznan, Poland
Research Site - Putrajaya, Malaysia
Research Site - Rio de Janeiro, Brazil
Research Site - Salgótarján, Hungary
Research Site - Szolnok, Hungary
Research Site - Warsaw, Poland
Research Site - Zalaegerszeg, Hungary
Research Site - Guntur, Andhra Pradesh, India
Research Site - Guwahati, Assam, India
Research Site - Fortaleza, Ceará, Brazil
Research Site - Budapest, HU, Hungary
Research Site - Budapest, HU, Hungary
Research Site - Debrecen, HU, Hungary
Research Site - Szeged, HU, Hungary
Research Site - Bangalore, Karnataka, India
Research Site - Belagavi, Karnataka, India
Research Site - Belagavi, Karnataka, India
Research Site - Calicut, Kerala, India
Research Site - Kochi, Kerala, India
Research Site - Thiruvananthapuram, Kerala, India
Research Site - Lublin, Lublin Voivodeship, Poland
Research Site - Indore, Madhya Pradesh, India
Research Site - Mumbai, Maharashtra, India
Research Site - Nagpur, Maharashtra, India
Research Site - Pune, Maharashtra, India
Research Site - Pune, Maharashtra, India
Research Site - Krakow, Malopolska, Poland
Research Site - Radom, Masovian Voivodeship, Poland
Research Site - Seremban, Negeri Sembilan, Malaysia
Research Site - Delhi, New Delhi, India
Research Site - Curitiba, Paraná, Brazil
Research Site - Seri Manjung, Perak, Malaysia
Research Site - Bialystok, Podlaskie Voivodeship, Poland
Research Site - Jaipur, Rajasthan, India

Showing 60 of 76 listed sites. See the official record for the complete list.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →